Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-12-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm has not commenced any operations. The firm has not generated any revenues.
OACC stock price ended at $10.7 on 火曜日, after rising 0.66%
On the latest trading day Mar 24, 2026, the stock price of OACC rose by 0.66%, climbing from $10.63 to $10.70. During the session, the stock saw a volatility of 0.66%, with prices oscillating between a daily low of $10.63 and a high of $10.70. Notably, trading volume dropped by 1.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 1.5K shares were traded, equating to a market value of approximately $263.0M.